Susceptibility Testing Methodology
Since 2001 BSAC has, through underwriting of a designated fund, supported the continued development of the methodology carried out at the Susceptibility Testing Method Centre based at NHS Wales, Cardiff.
Work in this area is overseen by a BSAC working party, the remit of which is to:
Individual chapters are available below:
Chapter 1
History and development of antimicrobial susceptibility testing methodology
July 2001
Chapter 2
Determination of minimum inhibitory concentrations
March 2006
Chapter 3
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
January 2005
Chapter 4
The development of the BSAC standardized method of disc diffusion testing
July 2001
Chapter 5
BSAC standardized disc susceptibility testing method
April 2007
Chapter 6
Detection of beta-lactamase-mediated resistance
August 2005
Chapter 7
Detection of methicillin/oxacillian resistance in staphylococci
July 2001
Chapter 8
Quality assurance of antimicrobial susceptibility testing by disc diffusion
July 2001
Chapter 9
Recommendations for susceptibility tests on fastidious organisms and those requiring special handling
July 2001
Chapter 10
Instrumentation in antimicrobial susceptibility testing
July 2001
Chapter 11
Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes
March 2004
Version 12 – May 2013
Version 11.1 – May 2012
Version 11 – March 2012
Version 10.2 – May 2011
Version 10.1 – April 2011
Version 10 – March 2011
Version 9 – March 2010
Version 8 – January 2009
Version 7.1 – February 2008
Version 7 – February 2008
Version 6.1 – February 2007
Version 6 – January 2007
Version 5 – January 2006
Version 4 – January 2005
Version 3.1 – July 2004
Version 3 – January 2004
Version 2.1.5 – November 2003
Version 2.1.4 – May 2003
Version 2.1.3 – February 2003
Version 2.1.2 – August 2002
Version 2.1.1 – January 2002
Version 2.1 – August 2001
Version 2 – July 2001